CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) closed fiscal year 2025 with a gross margin of 33.0 % and a net margin of -3.6 %.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) closed fiscal year 2025 with a gross margin of 33.0 % and a net margin of -3.6 %. The same year shows an EBITDA margin of 10.7 % and an EBIT margin of 0.6 %. The free cash flow margin was 12.9 %. Against the previous year the gross margin moved +0.1 pp and the net margin −4.1 pp. Across the period the gross margin ranges between 32.9 % in 2024 and 39.0 % in 2015. The series covers 18 fiscal years, from 2008 to 2025. Margins are expressed as a percentage of net revenue and are derived from the same figures as the income statement, taken from as-reported SEC EDGAR filings, with no restatements or adjustments of our own.
Fiscal year end: December
| 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin (%) | 38.51 % | 36.10 % | 33.95 % | 35.20 % | 34.71 % | 33.88 % | 36.42 % | 38.96 % | 38.46 % | 37.81 % | — | — | — | — | 36.79 % | 36.39 % | 32.88 % | 32.96 % |
| EBITDA margin (%) | -28.18 % | 22.15 % | -18.07 % | 22.71 % | 21.87 % | 21.28 % | 21.12 % | 22.10 % | 21.66 % | 22.58 % | 21.76 % | 20.95 % | 22.83 % | 24.16 % | 24.01 % | 22.55 % | 14.55 % | 10.67 % |
| EBIT margin (%) | -34.88 % | 14.48 % | -26.34 % | 15.25 % | 14.68 % | 12.99 % | 13.69 % | 15.14 % | 14.13 % | 15.52 % | 14.62 % | 13.40 % | 14.80 % | 16.66 % | 16.37 % | 14.95 % | 5.61 % | 0.63 % |
| Net margin (%) | -40.49 % | 9.77 % | -29.70 % | 9.59 % | 8.61 % | 8.82 % | 9.76 % | 10.95 % | 9.20 % | 6.64 % | 9.99 % | 9.61 % | 12.46 % | 11.04 % | 12.23 % | 11.49 % | 0.55 % | -3.59 % |
| FCF margin (%) | 6.49 % | 12.39 % | 11.13 % | 13.66 % | 14.20 % | 14.41 % | 14.96 % | 17.73 % | 15.44 % | 12.59 % | 13.12 % | 12.99 % | 13.00 % | 15.03 % | 7.42 % | 8.85 % | 12.39 % | 12.91 % |
